Inventor
Shengdar Tsai
Inventor
Charlestown, MA, US
Overview
Patents· 12 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes34%
C07KPeptides24%
C12YEnzymes21%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms17%
C40BCombinatorial chemistry3%
PatentTitleYear
10,844,403Increasing specificity for RNA-guided genome editing202010,738,303Comprehensive in vitro reporting of cleavage events by sequencing (CIRCLE-seq)202010,544,433Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome editing202010,526,589Multiplex guide RNAs202010,501,794Genomewide unbiased identification of DSBs evaluated by sequencing (GUIDE-seq)201910,138,476Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome editing201810,011,850Using RNA-guided FokI Nucleases (RFNs) to increase specificity for RNA-Guided Genome Editing20189,988,674Full interrogation of nuclease DSBs and sequencing (find-seq)20189,885,033'Increasing specificity for RNA-guided genome editing'20189,850,484Comprehensive in vitro reporting of cleavage events by sequencing (Circle-seq)20179,822,407'Genomewide unbiased identification of DSBs evaluated by sequencing (GUIDE-Seq)'20179,567,603'Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome editing'2017Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2017–2020Patents assigned to MASSACHUSETTS GEN HOSPITAL (12)· patent assignee history
2017–2020Based in Charlestown, MA, US· patent location history
2017–2020Based in Memphis, TN, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MASSACHUSETTS GEN HOSPITAL | 12 | 2017–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Charlestown, Massachusetts, US | 7 | 2017–2020 |
| Memphis, TN, US | 5 | 2017–2020 |